DA Davidson Initiates Coverage On Amrize with Neutral Rating, Announces Price Target of $50
DA Davidson analyst Garik Shmois initiates coverage on Amrize (NYSE:AMRZ) with a Neutral rating and announces Price Target of $50.
Read original at benzingaStocks · News reference
Oppenheimer Maintains Outperform on Amrize, Lowers Price Target to $65
Oppenheimer analyst Bryan Blair maintains Amrize (NYSE:AMRZ) with a Outperform and lowers the price target from $68 to $65.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 21, 2026, 5:56 PM
- Checked
- Jul 21, 2026, 5:57 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K filing — Amrize Ltd (AMRZ)
Filed: 2026-08-24 AccNo: 0001140361-26-034208 Size: 487 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarAmrize Appoints Samuel J. Poletti CFO, Effective Immediately, Succeeding Baris Oran
The Amrize (NYSE:AMRZ) Board of Directors has appointed Samuel J. Poletti as Chief Financial Officer, effective August 24. Poletti succeeds Baris Oran, who is stepping down for personal reasons. The company has also
Read original at benzingaStephens & Co. Maintains Overweight on Amrize, Lowers Price Target to $54
Stephens & Co. analyst Trey Grooms maintains Amrize (NYSE:AMRZ) with a Overweight and lowers the price target from $65 to $54.
Read original at benzinga